Patient Groups/UK

Patient Groups are organisations which claim to represent the interests of patients suffering various illnesses. Some are funded, at least in part, by pharmaceutical companies which sell treatments for the relevant illnesses.

Some UK patient groups include:

• Arthritis Care
• Association of Medical Research Charities
• Asthma UK
• Beating Bowel Cancer
• Bowel Cancer UK
• British Heart Foundation
• British Lung Foundation
• Depression Alliance
• Diabetes UK
• Diabetes Insight
• Ekbom Support Group
• Epilepsy Action UK
• Europa Uomo
• Heart UK
• The Diabetes Research & Wellness Foundation
• The Patients Forum
• Myeloma Euronet
• National Osteoporosis Society
• National Rheumatoid Arthritis Society
• Parkinson's Disease Society
• Proventus
• SANE (UK)
• Women Fighting for Herceptin

SourceWatch Resources

• Health Care
• Doctor Run Charities
• National Institute for Health and Clinical Excellence (NICE)
• Patient Groups
• Patient Groups/Australia
• Patient Groups/South Africa
• Patient Groups/International
• Patient Groups/New Zealand
• Patient Groups/US

Other SourceWatch Resources

• National Institute for Clinical Excellence

External links

• Andrew Jack, "Too close for comfort?", British Medical Journal, June 30 2006. (Sub req'd until June 2007).
• Jo Revill, "Cancer drug firm's PR trip sparks a row: MPs and charity officials defend paid-for visit to see 'gold standard' treatment at French hospital", The Observer, July 2, 2006.
• Douglas Ball, Klara Tisocki and Andrew Herxheimer, "Advertising and disclosure of funding on patient organisation websites: a cross-sectional survey", BMC Public Health, August 3, 2006.
• David Miller 'This campaign brought to you by...' Spinwatch, 29 October 2006.
• Jeremy Laurance, "Drug firms bankroll attacks on NHS: Charities' protests against Nice funded by pharmaceutical companies", The Independent (UK), October 1, 2008.
• Jeremy Laurance, Analysis: Are patient protests being manipulated?", The Independent (UK), October 1, 2008.
• "Charities not in the pocket of pharma", Pharmceutical Marketing, October 1, 2008.

This article is a stub. You can help by expanding it.